Muscarinic Receptor Agonists in Alzheimer's Disease: More Than Just Symptomatic Treatment?

ISSN： 1172-7047

Source： CNS Drugs, Vol.12, Iss.3, 1999-09, pp. : 197-214

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dopamine Agonists in Parkinsons Disease: What is Their Role in Early Treatment?

By Stocchi F.

CNS Drugs, Vol. 10, Iss. 3, 1998-09 ,pp. : 159-170

Adis International

Access to resources Recommend Favorite

Muscarinic agonists for the treatment of Alzheimer's disease: progress and perspectives

By Fisher A.

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 10, 1997-10 ,pp. : 1395-1412

Informa Healthcare

Access to resources Recommend Favorite

TRAIL a target rather than a treatment?

Inpharma, Vol. 1, Iss. 1254, 2000-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Muscarinic Receptor Agonists and Antagonists in the Treatment of Alzheimer's Disease

Current Pharmaceutical Design, Vol. 11, Iss. 26, 2005-10 ,pp. : 3353-3361

Bentham Science Publishers

Access to resources Recommend Favorite

Kidney disease a barrier to HIV treatment?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 543, 2007-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite